Cadence Bank’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | $14.5M | Buy |
63,344
+224
| +0.4% | +$51K | 0.85% | 26 |
|
|
2025
Q3 | $14.6M | Sell |
63,120
-150
| -0.2% | -$30.5K | 0.89% | 24 |
|
|
2025
Q2 | $11.7M | Sell |
63,270
-39,083
| -38% | -$7.26M | 0.77% | 26 |
|
|
2025
Q1 | $21.4M | Buy |
102,353
+1,063
| +1% | +$207K | 1.53% | 13 |
|
|
2024
Q4 | $18M | Buy |
101,290
+1,208
| +1% | +$222K | 1.22% | 16 |
|
|
2024
Q3 | $19.8M | Buy |
100,082
+688
| +0.7% | +$128K | 1.36% | 15 |
|
|
2024
Q2 | $17M | Sell |
99,394
-2,704
| -3% | -$448K | 1.28% | 14 |
|
|
2024
Q1 | $18.6M | Sell |
102,098
-875
| -0.8% | -$151K | 1.35% | 16 |
|
|
2023
Q4 | $16M | Sell |
102,973
-498
| -0.5% | -$72.6K | 1.3% | 15 |
|
|
2023
Q3 | $15.4M | Sell |
103,471
-1,287
| -1% | -$189K | 1.36% | 13 |
|
|
2023
Q2 | $14.1M | Buy |
104,758
+5,698
| +6% | +$836K | 1.23% | 14 |
|
|
2023
Q1 | $15.8M | Buy |
99,060
+736
| +0.7% | +$113K | 1.45% | 14 |
|
|
2022
Q4 | $15.9M | Buy |
98,324
+1,051
| +1% | +$161K | 1.47% | 12 |
|
|
2022
Q3 | $13.1M | Buy |
97,273
+16,415
| +20% | +$2.36M | 1.35% | 12 |
|
|
2022
Q2 | $12.4M | Sell |
80,858
-1,071
| -1% | -$164K | 1.78% | 9 |
|
|
2022
Q1 | $13.3M | Sell |
81,929
-11,256
| -12% | -$1.64M | 1.65% | 13 |
|
|
2021
Q4 | $12.6M | Buy |
93,185
+973
| +1% | +$115K | 1.57% | 13 |
|
|
2021
Q3 | $9.95M | Buy |
92,212
+313
| +0.3% | +$35.8K | 1.39% | 15 |
|
|
2021
Q2 | $10.4M | Buy |
91,899
+1,112
| +1% | +$125K | 1.5% | 14 |
|
|
2021
Q1 | $9.82M | Sell |
90,787
-1,070
| -1% | -$114K | 1.49% | 14 |
|
|
2020
Q4 | $9.84M | Buy |
91,857
+5,568
| +6% | +$535K | 1.54% | 11 |
|
|
2020
Q3 | $7.56M | Sell |
86,289
-1,047
| -1% | -$98.6K | 1.49% | 17 |
|
|
2020
Q2 | $8.57M | Buy |
87,336
+2,118
| +2% | +$186K | 1.77% | 9 |
|
|
2020
Q1 | $6.49M | Buy |
85,218
+4,212
| +5% | +$359K | 1.64% | 10 |
|
|
2019
Q4 | $7.17M | Buy |
81,006
+316
| +0.4% | +$26.2K | 1.33% | 12 |
|
|
2019
Q3 | $6.11M | Buy |
80,690
+33,869
| +72% | +$2.32M | 0.58% | 25 |
|
|
2019
Q2 | $3.4M | Buy |
46,821
+3,466
| +8% | +$272K | 0.33% | 56 |
|
|
2019
Q1 | $3.49M | Buy |
43,355
+770
| +2% | +$63K | 0.35% | 50 |
|
|
2018
Q4 | $3.93M | Buy |
42,585
+2,382
| +6% | +$209K | 0.46% | 34 |
|
|
2018
Q3 | $3.8M | Buy |
40,203
+366
| +0.9% | +$34.7K | 0.35% | 42 |
|
|
2018
Q2 | $3.69M | Buy |
39,837
+13,321
| +50% | +$1.3M | 0.33% | 43 |
|
|
2018
Q1 | $2.51M | Buy |
26,516
+362
| +1% | +$39.8K | 0.24% | 58 |
|
|
2017
Q4 | $2.53M | Buy |
+26,154
| New | +$2.46M | 0.24% | 59 |
|
Other funds holding ABBV
Cadence Bank's ABBV Position: Q4 2025 in Review
Cadence Bank increased its AbbVie (ABBV) stake by 0.35% in Q4 2025, buying an estimated $51K and bringing the position to 63,344 shares worth $14.5M. The position accounts for 0.85% of the portfolio, ranked #26.
Cadence Bank first reported a position in ABBV in Q4 2017 and has held it in 33 quarters since. The position peaked at $21.4M in Q1 2025. 4,147 funds tracked by Wall St. Rank hold ABBV as of Q4 2025.
- Cadence Bank held 63,344 shares of AbbVie worth $14.5M as of Q4 2025.
- Cadence Bank bought 224 AbbVie shares in Q4 2025, an estimated $51K.
- AbbVie made up 0.85% of Cadence Bank's portfolio in Q4 2025, its #26 holding.
- Cadence Bank first reported a position in AbbVie in Q4 2017 and has held it in 33 quarters since.
- Cadence Bank's AbbVie position peaked at $21.4M in Q1 2025.
- 4,147 funds tracked by Wall St. Rank held AbbVie as of Q4 2025.
Based on Cadence Bank's 13F filing for Q4 2025, filed 30 Jan 2026.